Based on data from the past 90 days ending February 11, 2026, Pfizer's three largest insider shareholders are Executive Vice President Frank A Damelio (555.94K shares), Chairman & Ceo Albert Bourla (367.59K shares), President R&D Mikael Dolsten (321.73K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Frank A Damelio | Executive Vice President | 555,941 | 01 Mar, 2022 |
| Albert Bourla | Chairman & Ceo | 367,589 | 03 Mar, 2025 |
| Mikael Dolsten | President R&D | 321,729 | 29 Feb, 2024 |
| John D Young | Group President | 312,704 | 12 Nov, 2021 |
| Sally Susman | Executive Vice President | 168,909 | 03 Mar, 2025 |
| Douglas M Lankler | Executive Vice President | 159,240 | 03 Mar, 2025 |
| Christoffel Boshoff | President And R&D | 155,645 | 02 Feb, 2026 |
| William Pao | Executive Vice President | 97,765 | 03 Apr, 2023 |
| Rady A Johnson | Executive Vice President | 97,153 | 27 Feb, 2024 |
| Alexander R Mackenzie | Executive Vice President | 87,280 | 06 Dec, 2021 |
| Michael Mcdermott | Executive Vice President | 75,958 | 03 Mar, 2025 |
| Germay Alexandre De | Executive Vice President | 74,377 | 28 Feb, 2024 |
| Lidia Fonseca | Executive Vice President | 41,829 | 03 Mar, 2025 |
| William R Jr Carapezzi | Executive Vice President | 38,146 | 13 May, 2022 |
| David M Denton | Chief Financial Officer & Evp | 37,919 | 03 Jun, 2024 |
| Ronald E Blaylock | 32,457 | 14 Feb, 2025 | |
| Angela Hwang | President And Global Biopharma | 29,778 | 28 Feb, 2023 |
| Aamir Malik | Executive Vice President | 29,548 | 03 Sep, 2024 |
| Payal Sahni | Executive Vice President | 25,928 | 03 Mar, 2025 |
| Jennifer B. Damico | Svp & Controller | 11,850 | 06 Mar, 2025 |
| Scott Gottlieb | 10,000 | 31 Oct, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 30 Jan, 2026 | Christoffel Boshoff | Common Stock | D | 12,887 | $26.44 | 155,645 | D | F |
| 04 Mar, 2025 | Jennifer B. Damico | Common Stock | A | 5,583 | $0.00 | 14,350 | D | A |
| 04 Mar, 2025 | Jennifer B. Damico | Common Stock | D | 2,500 | $25.93 | 11,850 | D | S |
| 04 Mar, 2025 | Jennifer B. Damico | - | - | 11,850 | D | |||
| 27 Feb, 2025 | Sally Susman | Common Stock | A | 85,182 | $31.31 | 250,866 | D | M |
| 27 Feb, 2025 | Sally Susman | Common Stock | D | 2,178 | $26.10 | 248,688 | D | F |
| 27 Feb, 2025 | Sally Susman | Common Stock | D | 79,779 | $26.06 | 168,909 | D | F |
| 27 Feb, 2025 | Lidia Fonseca | Common Stock | D | 68,022 | $26.06 | 41,829 | D | F |
| 27 Feb, 2025 | Lidia Fonseca | Common Stock | A | 72,629 | $31.31 | 111,534 | D | M |
| 27 Feb, 2025 | Lidia Fonseca | Common Stock | D | 1,683 | $26.10 | 109,851 | D | F |
| 27 Feb, 2025 | Douglas M Lankler | Common Stock | D | 3,589 | $26.10 | 306,201 | D | F |
| 27 Feb, 2025 | Douglas M Lankler | Common Stock | A | 156,914 | $31.31 | 309,790 | D | M |
| 27 Feb, 2025 | Douglas M Lankler | Common Stock | D | 146,961 | $26.06 | 159,240 | D | F |
| 27 Feb, 2025 | Albert Bourla | Common Stock | A | 582,823 | $31.31 | 931,744 | D | M |
| 27 Feb, 2025 | Albert Bourla | Common Stock | D | 545,855 | $26.06 | 367,589 | D | F |
| 27 Feb, 2025 | Albert Bourla | Common Stock | D | 18,300 | $26.10 | 913,444 | D | F |
| 27 Feb, 2025 | Albert Bourla | - | - | 931,744 | D | |||
| 27 Feb, 2025 | Jennifer B. Damico | Common Stock | D | 749 | $26.10 | 29,761 | D | F |
| 27 Feb, 2025 | Jennifer B. Damico | - | - | 30,510 | D | |||
| 27 Feb, 2025 | Jennifer B. Damico | Common Stock | D | 553 | $26.10 | 30,510 | D | F |